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Background: Defining tumour volume for treatment response and radiotherapy planning is challenging and prone
to inter- and intra-observer variability. Various automated tumour delineation methods have been proposed in the
literature, each having abilities and limitations. Therefore, there is a need to provide clinicians with practical information
on delineation method selection.
Methods: Six different automated positron emission tomography (PET) delineation methods were evaluated
and compared using National Electrical Manufacturer Association image quality (NEMA IQ) phantom data and
three in-house synthetic phantoms with clinically relevant lesion shapes including spheres with necrotic core
and irregular shapes. The impact of different contrast ratios, emission counts, realisations and reconstruction
algorithms on delineation performance was also studied using similarity index (SI) and percentage volume error
(%VE) as performance measures.
Results: With the NEMA IQ phantom, contrast thresholding (CT) performed best on average for all sphere sizes
and parameter settings (SI = 0.83; %VE = 5.65% ± 24.34%). Adaptive thresholding at 40% (AT40) was the next best
method and required no prior parameter tuning (SI = 0.78; %VE = 23.22% ± 70.83%). When using SUV harmonisation
filtering prior to delineation (EQ.PET), AT40 remains the best method without prior parameter tuning (SI = 0.81;
%VE = 11.39% ± 85.28%).
For necrotic core spheres and irregular shapes of the synthetic phantoms, CT remained the best performing method
(SI = 0.83; %VE = 26.31% ± 38.26% and SI = 0.62; %VE = 24.52% ± 46.89%, respectively). The second best method was
fuzzy locally adaptive Bayesian (FLAB) (SI = 0.83; %VE = 29.51% ± 81.79%) for necrotic core sphere and AT40 (SI = 0.58;
%VE = 25.11% ± 32.41%) for irregular shapes. When using EQ.PET prior to delineation, AT40 was the best performing
method without prior parameter tuning for both necrotic core (SI = 0.83; %VE = 27.98% ± 59.58%) and complex shapes
phantoms (SI = 0.61; %VE = 14.83% ± 49.39%).
Conclusions: CT and AT40/AT50 are recommended for all lesion sizes and contrasts. Overall, considering background
uptake information improves PET delineation accuracy. Applying EQ.PET prior to delineation improves accuracy and
reduces coefficient of variation (CV) across different reconstructions and acquisitions.
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18F-2-Fluoro-2-deoxy-D-glucose (18F-FDG) positron emis-
sion tomography (PET) provides information about the
metabolic activities of tissue cells and is widely used in
cancer management. Cancer cells have increased cellu-
lar metabolism of glucose and therefore their 18F-FDG
uptake is typically higher than healthy tissue cells [1].* Correspondence: matthew.kelly@siemens.com
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in any medium, provided the original work is pBased on this uptake, the location and extent of cancerous
tumours can be determined to support tumour staging,
evaluation of treatment response and radiotherapy plan-
ning. FDG PET provides complementary information to
anatomical imaging modalities such as computed tomog-
raphy to aid the differentiation between healthy and
malignant tissue. It also allows determination of metabolic
tumour volume (MTV) and consequently total lesion
glycolysis (TLG) [2] which have shown prognostic and
predictive value in oncology [3,4]. PET can also bes an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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ment planning for more accurate gross tumour volume
(GTV) definition [5]. In addition, 18F-FDG PET can show
metabolic inhomogeneity inside the tumour which can be
used to identify areas in the tumour which may benefit
from additional radiation [6].
Currently, tumour volume delineation is typically per-
formed manually by visual interpretation of PET or
computed tomography images, which is prone to inter-
and intra-observer variability [7-9]. The relatively low
spatial resolution of PET and noise contribute to this
variation by making the lesion boundaries less well
defined. Numerous studies have proposed a variety of
automatic delineation methods to overcome the subject-
ivity of tumour volume delineation, with the most com-
monly used being thresholding a volume of interest
(VOI) including the tumour by 40% or 50% of maximum
standard uptake value (SUVmax) within the VOI. This
method is used in routine clinical practice and provides
clinical benefits [2,10]. Other automatic PET delineation
methods include contrast-oriented [11], gradient-based
[12], adaptive thresholding [10], background-subtracted
relative-threshold level [13] and statistical modelling
(FLAB) [14] and their performance have been compared
in several studies [15-18]. These studies used either
clinical data with histology, computed tomography or
manually drawn contours as ground truth or phantom
or simulation data with known ground truth but re-
constructed with a single reconstruction protocol. They
showed that the performance of a delineation method
depends on imaging parameters (i.e. reconstruction set-
tings, image noise level, tumour characteristics, contrast)
and you need to choose the suitable delineation method
accordingly to get the optimum results.
In this study, we used National Electrical Manufacturer
Association (NEMA) image quality (IQ) [19] phantom
data acquired with a range of contrasts and emission
counts and reconstructed with a range of reconstruction
protocols, using the manufactured sphere sizes as ground
truth. Additionally more clinically relevant, heterogeneous
and irregularly shaped lesions were studied using synthetic
phantoms created in-house and reconstructed with the
same set of contrasts, emission counts and reconstruction
protocols as for the NEMA IQ phantom. Using phantom
data enabled us to validate against a real ground truth and
therefore assess the performance of the methods more
precisely and objectively. We used this phantom data to
evaluate a range of automatic tumour delineation methods
for PET data which use SUV as the classification feature
(first-order feature), independently from the inventors of
the methods themselves.
The performance of automatic PET delineation methods
based on SUV will be affected by factors known to impact
SUV such as scanner type and reconstruction parameters[20]. However, there have been limited studies that
considered the impact of these factors on tumour volume
assessment [21]. Therefore, an additional objective of this
study was to assess quantitatively the effect of those factors
on the automatic delineation methods and compare their
performance before and after correction for differences in
recovery [22].
In practice, it is very important to consider the clinical
objective when selecting the delineation method. For
example, in radiotherapy, the aim is to delineate the
extent of the tumour as precisely as possible to avoid
unnecessary irradiation of healthy tissue. As such, the
mean accuracy of the method would be the key per-
formance measure. For tumour response assessment,
the objective is accurate determination of change in
metabolic volume. As such, it may be preferred to use a
method which is consistent across all reconstructions
and acquisitions accepting any tendency to over- or
under-estimate the true volume. The objective of this
study is to provide information to inform the selection
of delineation method.
Methods
Six different automatic PET delineation methods were
evaluated using NEMA IQ phantom and three additional
synthetic phantom data sets created in-house.
Physical phantom
The NEMA IQ phantom was prepared with an 18F solu-
tion to produce a background activity concentration of
5.2 kBq/ml. The six spheres (10-, 13-, 17-, 22-, 28- and
37-mm diameter) were filled to produce a hot sphere-to-
background ratio of either 4:1 or 8:1. The phantom was
placed in the 64 slice Biograph mCT scanner (Siemens
Healthcare, Erlangen, Germany) such that the plane
through the centre of the spheres was aligned with the
centre of the PET axial field of view and the centre of the
lung insert was aligned with the centre of the transaxial
field of view. For each concentration ratio, a 1-h listmode
acquisition was performed. Using an electrocardiogram
(ECG) simulator, the listmode data was gated and divided
into ten replicate sinograms for each of 3.0 × 107
and 6.0 × 107 net true coincidences. Each replicate was
reconstructed with four different reconstruction protocols
representing a range of clinically relevant configurations;
namely: 3-dimensional ordinary Poisson ordered subset
expectation maximisation (3D OP-OSEM) with 3 itera-
tions, 24 subsets and 5-mm full width at half maximum
(FWHM) Gaussian post filter; 3D OP-OSEM+ time of
flight (TOF) with 2 iterations, 21 subsets, 2-mm FWHM
Gaussian post filter; 3D OP-OSEM+ point spread func-
tion (PSF) with 3 iterations, 24 subsets and 2-mm FWHM
Gaussian post filter; 3D PSF + TOF with 2 iterations, 21
subsets and 2-mm FWHM Gaussian post filter. Each
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200 and 400 × 400 matrix, giving voxel dimensions of
4.073 × 4.073 mm with a 2.027-mm slice thickness, and
2.036 × 2.036 mm with a 2.027-mm slice thickness, respect-
ively. In total, 6 (spheres) × 2 (contrasts) × 4 (reconstruc-
tion protocols) × 3 (emission counts) × 10 (replicates) × 2
(matrix sizes) were acquired, making a total of 2,880
objects to be delineated.
Synthetic phantoms
In addition to the physical phantom, three different syn-
thetic phantoms were designed to evaluate the performance
of the automated PET delineation methods with more
complex lesion shapes. All three synthetic phantoms have a
cylindrical body (diameter = 300 mm, length = 221 mm). In
the first phantom, seven spheres were placed radially
around the central transaxial slice with diameters of 7, 10,
13, 17, 22, 28 and 37 mm (Figure 1a). A similar configur-
ation was used for the second phantom (Figure 1b) but
with all the spheres having a diameter of 42 mm and
including necrotic cores of the same diameters as the
spheres placed in the first phantom. The third phantom
(Figure 1c) included six irregular shapes (Figure 2) selected
from real patient data. Only the contours were used in the
simulation, and the uptake was assumed constant within
the contour of the lesion, which was digitised to match
the image matrix. PET equivalent data for these synthetic
phantoms were simulated using in-house PET simulator
software that forward projects the input image using the
geometry of the Siemens mCT (Siemens Healthcare,
Erlangen, Germany) [23], including effects of detector sen-
sitivity, attenuation, scatter, randoms and Poisson noise.Figure 1 The three synthetic phantom configurations before (first row)
examples have a contrast of 8 to 1, 60-M emission counts and is reconstructe
200 × 200 pixels matrix size; a) including 7 spheres with diameters of 7, 10, 13
diameters of 42 mm and inner diameters of 7, 10, 13, 17, 22, 28 and 37 mm, cThe simulations included 3.0 × 107 or 6.0 × 107 true events
and 5.0 × 107 or 10.0 × 107 random events, respectively,
representing a typical patient acquisition (weight of 75 kg)
with approximately 2.5 or 5 min per bed position and
10 mCi injection (scanned 45 min after injection). Ten
replicate sinograms were generated for each of 3.0 × 107
and 6.0 × 107 net true coincidences similar to the real
phantom. The generated sinograms and corresponding
μ-maps for attenuation correction were reconstructed
with the same reconstruction algorithms available on the
commercial system. The same reconstruction parameters
were used for the synthetic phantom as for the physical
NEMA IQ to allow direct comparison.
EQ.PET filter
SUV is intended to reduce the effect of patient size and
body composition relative to the injected dose of radio-
tracer and making it possible to compare between differ-
ent studies and patients [4,24]. However, there are other
factors that can introduce bias to the quantification
process, such as reconstruction protocol. An additional
reconstruction-specific Gaussian filter (EQ.PET filter)
was proposed to overcome this bias [22]. The filter size
for a given reconstruction protocol is determined by
minimising the root mean squared error (RMSE) between
the recovery coefficients (RCs) of a NEMA IQ phantom
reconstructed with that protocol and those of a common
reference [10]. The Gaussian filters aligning the recovery
coefficients for each reconstruction protocol to the refer-
ence have been applied prior to automatic delineation
and the results compared to those generated with no
additional filtering. The EQ.PET filter sizes for OP (withand after reconstruction (second row). The presented reconstructed
d with OPTOF (2 iterations, 21 subsets, 2-mm post filter size) and
, 17, 22, 28 and 37 mm, b) including 7 spheres with necrotic core, outer
) including 6 different lesion shapes extracted from real patient data.
Figure 2 Original binary masks (axial view) of example lesion shapes created from real patient data. Volume (Vol) of each lesion is shown
below each mask.
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filter), OP + TOF (with 2 iterations, 21 subsets, 2-mm
FWHM Gaussian post filter), PSF (with 3 iterations, 24
subsets and 2-mm FWHM Gaussian post filter) and
PSF + TOF (with 2 iterations, 21 subsets and 2-mm
FWHM Gaussian post filter) were 4.76, 7.35, 6.52 and
7.41, respectively.
Automated PET delineation methods
For each phantom, each object being delineated was
enclosed in a bounding VOI containing no other objects.
Six different automatic PET delineation methods were
applied to the VOIs, with and without prior EQ.PET fil-
tering, including:
 Thresholding at 40% SUVmax (T40): delineates all
voxels with SUVs above or equal to 40% of the
maximum SUV inside the selected VOI.
 Thresholding at 50% SUVmax (T50): delineates all
voxels with SUVs above or equal to 50% of the
maximum SUV inside the selected VOI.
 Contrast thresholding (CT) [11]: uses an optimal
threshold (T) for the data inside the selected VOI
that was calculated as follows:
T ¼ amSUV 70 þ b BG ð1Þ
where mSUV70 is the mean SUV in the region
generated by thresholding the VOI at 70% of
SUVmax and BG is the mean SUV in a background
region. Parameters a and b are calculated using a set
of NEMA IQ phantom acquisitions to determine a
regression function that best represents therelationship between the optimal threshold for that
phantom and its mSUV70 and BG. In this study, we
performed the regression analysis using the NEMA
IQ phantom data described in the Physical phantom
section.
 Adaptive thresholding at 40% SUVmax (AT40) [10]:
adapts the threshold value inside the selected VOI
relative to mean background SUV (BG):
T ¼ 0:4  SUVmax−BGð Þ þ BG ð2Þ
 Adaptive thresholding at 50% SUVmax (AT50) [10]:
adapts the threshold value inside the selected VOI
relative mean background SUV:
T ¼ 0:5  SUVmax−BGð Þ þ BG ð3Þ
 Fuzzy locally adaptive Bayesian (FLAB) [14]: an
unsupervised statistical method using a fuzzy model
within the Bayesian framework. It allows coexistence
of voxels belonging to one of the two hard classes
and voxels belonging to a ‘fuzzy level’ inside the
selected VOI.
For methods which required background uptake infor-
mation, a spherical background region (20 voxels in
diameter) was manually positioned in the body of the
phantom away from any spherical inserts or synthetic
lesions. All the above methods except FLAB have been
developed in house. The FLAB implementation was
acquired from the inventors directly and was applied
without any modifications in the method itself or its
parameter settings.
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Given the true position and size of phantom spheres is
known for the NEMA IQ phantom, ground truth was
created on the PET data by fitting a sphere of the appro-
priate volume to each of the phantom spheres to create
a binary mask. The VOIs generated with the automated
methods described above were validated against this
ground truth. For the synthetic phantoms, the ground
truths were the binary masks used as input to the PET
simulator.
Two evaluation measures were used to measure the
agreement between the ground truth and the delineated
lesions: similarity index (SI) (Equation 4) and percentage
volume error (%VE) (Equation 5). These were calculated
as follows:
SI ¼ 2 GT∩PETð Þ
GTj j þ PETj jð Þ ð4Þ




where GT is the number of voxels in the ground truth
binary mask, PET is the number of voxels in the delin-
eated binary mask produced by the delineation method,
VolPET is the volume of the automatically delineated
sphere and Voltrue is the mathematically calculated vol-
ume in case of the NEMA IQ phantom and the initial
mask volume for the synthetic phantoms.
Results and discussion
Automatically delineated VOIs from the NEMA IQ
phantom and the synthetic phantoms were compared
against ground truth and SI and %VE were calculated for
all lesion sizes, clinically relevant reconstruction protocols,
contrasts and emission counts. The results are presented
with and without applying prior EQ.PET filtering.
Results for NEMA IQ phantom
Figure 3 shows the validation results using SI (3a, 3b)
and %VE (3c, 3d) for each delineation method, across all
clinical reconstructions and sphere sizes in the NEMA
IQ phantom with (3a, 3c) and without (3b, 3d) EQ.PET
filtering. Ideally, SI should be 1 and %VE should be 0%.
Consistency of volume delineation across all reconstruc-
tions and acquisitions was measured using the coeffi-




where mean is the mean delineated volume for a set of
lesions and SD is the corresponding standard deviation.
Lower CV values represent higher consistency of the
delineated volumes across different reconstructions and
acquisitions. Across all spheres sizes, CT had the highestmean SI (average over all spheres is 0.83) and lowest %
VE (5.56% ± 24.34%; mean ± SD). Given the dependence
of the methods’ performance on lesion size, the data was
divided into two size groups, large (17, 22, 28 and 37 mm)
and small (10 and 13 mm), and average values were
calculated for each group. For small spheres, only those
methods explicitly considering background uptake (CT,
AT40 and AT50) produced sensible delineations, whilst
the other methods frequently overestimated the lesion
volumes, including a large proportion of background
region in the delineation (Figure 3). For threshold-based
methods, considering background uptake reduced the
inclusion of background by ensuring the threshold value
used for delineation was above the mean background
value, even for low contrast lesions. Effect of lesion con-
trast and number of emission counts were also investi-
gated. For small lesions, higher contrast values improved
SI, %VE and CV; increased emission counts slightly
improved SI and %VE but had no effect on CV. For large
lesions, increasing contrast or emission counts slightly
improved SI and %VE but did not have significant effect
on CV. Whilst increasing counts would be expected to
reduce the variation across the ten replicates for a given
reconstruction protocol, the variation due to differences
in reconstruction protocol dominates this effect resulting
in minimal impact on CV.
Following application of the appropriate EQ.PET filter,
AT40 had the highest mean SI (0.81) and lowest %VE
(11.39% ± 85.28%); however, this SI remains slightly
lower and the %VE slightly higher than those of the un-
filtered CT method (Figure 3). EQ.PET filtering was not
applied to CT since the method parameters were already
optimised for each reconstruction. The consistency of the
delineated volume across reconstructions improved using
EQ.PET filtering: mean CV was reduced approximately
1.6-fold for all sphere sizes and delineation methods. The
CV values calculated across all reconstructions and acqui-
sitions for each delineation method, with and without EQ.
PET filtering, are shown in Figure 4. For large lesions, the
average CV was 0.2 for all delineation methods, whereas
for small lesions the CV could reach more than 1. After
applying EQ.PET, CV decreased on average to less than
0.1 for large lesions and 0.9 for small lesions. Filtering also
increased accuracy (SI) for large spheres from 0.81 to 0.85
but reduced accuracy for small spheres from 0.59 to 0.49.
As it was presented in the results above, effect of apply-
ing EQ.PET filter can be different on large and small
lesions. The filtering reduces noise in the image and
makes it more homogeneous but also reduces contrast
between foreground and background. Homogeneity con-
tributes to consistency across all reconstructions and
acquisitions by making these images more similar to each
other in terms of SUVs. It can also suppress local maxima
in background regions, preventing their inclusion in the
Figure 3 SI (a, b) and %VE (c, d) for all methods based on validation on NEMA IQ phantom. For each method a group of 6 boxplots are
presented, each belonging to one sphere size, with (b, d) and without (a, c) prior filtering. Each boxplot represents the distribution (mean and
quartiles) of validation results from all clinical reconstructions. In case of %VE, the y-axis range has been limited to −100 to 200 for better readability.
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lesions. EQ.PET typically improved accuracy for large
lesions; for example, the AT40 mean %VE decreased
from −34.27% to −22.65% for large lesions. For small
lesions, EQ.PET typically reduced delineation accuracy;
for example, the AT40 mean %VE increased from
−1.14% to 79.48% for small lesions. Small lesions often
have low image contrast and by further reducing thecontrast with EQ.PET, background regions are more likely
to be included in the delineation.
Results for synthetic phantoms
The results from the first synthetic phantom with NEMA
size spheres are in line with those from the physical
NEMA IQ phantom data as we observed that CT also
showed the highest SI (0.73). Similarly to what was done
Figure 4 CV of delineated volumes on NEMA IQ phantom data across different reconstructions and acquisitions. CV values are presented
with respect to lesion size for all methods with (dashed lines) and without (solid lines) prior EQ.PET filtering (left). A zoomed version of the plot
over a closer range of CV values is shown on the right.
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results, the data was divided into two groups of large
(17, 22, 28 and 37 mm) and small (7, 10 and 13 mm)
spheres. Adding an extra small sphere (7 mm) to the
phantom decreased the accuracy for delineating small
spheres for all methods with respect to the physical
phantom. For example, CT accuracy (SI) for small spheres
decreased from 0.73 to 0.54, although it remained the
same as the physical phantom for large spheres. After
applying the EQ.PET filter, AT40 had the highest SI (0.71)
and the mean CV improved approximately 1.6-fold for all
sphere sizes and delineation methods. The accuracy (SI)
for small spheres decreased from 0.43 to 0.38 and for large
spheres increased from 0.80 to 0.84. The effect of contrast
and number of emission counts was similar to the physical
phantom.
Figure 5 shows the results (SI) from the synthetic
phantom with necrotic core spheres with (5c, 5d) and
without (5a, 5b) prior EQ.PET filtering. The validation
has been performed based on both the necrotic core and
the outer layer (Figure 6) since focusing only on the
outer layer may not reflect the ability of the method to
detect the necrotic core. On average, when validating on
the outer layer, CT has the highest SI (0.83) with %VE of
26.31% ± 38.26% and after applying EQ.PET filter, AT40
has the highest SI (0.83) with %VE of 27.98% ± 59.58%.
In addition, similarly to the physical NEMA IQ phantom
results, filtering reduced mean CV approximately 2-fold
for small cores and approximately 2.4-fold for large
cores for all delineation methods (Figure 7). For large
necrotic cores, filtering had negligible effect on accuracy
(SI) and for small necrotic cores, the accuracy slightly
increased from 0.86 to 0.89. When validating on the
necrotic core, AT50 has the highest SI without (0.68; %
VE = 35.26% ± 56.45%) and with (0.48; %VE = 57.5% ±
31.92%) prior EQ.PET filtering. Furthermore, filtering
reduced the mean accuracy (SI) for small cores from0.36 to 0.04 and from 0.78 to 0.52 for large cores. CV
increased approximately 1.5-fold for the small cores and
approximately 1.6-fold for the large ones.
The validation results on the phantom with irregular
shapes show that CT has the highest SI (0.62; %VE =
24.52% ± 46.89%) for all shapes (Figure 8). After applying
EQ.PET filtering AT40 has the highest SI (0.61; %VE =
14.83% ± 49.39%) which is a similar SI as CT without
prior filtering but improved %VE. Prior filtering slightly
improved overall mean accuracy but CV reduced approxi-
mately 1.4-fold. The more the shapes deviate from a
sphere, the less accurate the delineation results. The algo-
rithms capable of delineating small lesions performed
better on these shapes since they were able to delineate
small details better.Practical insights on selecting a lesion delineation method
To produce guidelines to assist selection of the best
method for a specific data type, the effects of different
data parameters including lesion size, lesion contrast,
reconstruction protocol and number of emission counts
have been studied. From our results, lesion size and con-
trast had the most impact on method selection whereas
reconstruction parameters and number of emission counts
had a lower impact but they can be used to fine tune the
accuracy. A summary of the methods’ performance on
NEMA IQ phantom data, based on different parameters, is
shown in Figure 9. This diagram provides an overview of
the relative performance of the best performing methods
for different situations and provides an indication of the
level of accuracy you can expect in each situation. The
parameters which have impact on the algorithm perform-
ance are shown as diamonds and option for each param-
eter is indicated next to them. Next to each option, the
performance of the selected method is presented in terms
of %VE ± SD in brackets. Depending on the type of data
Figure 5 SI based on the synthetic phantom with necrotic core spheres. Results are presented for necrotic core (a, c) and non-necrotic layer
(b, d) for all methods. The results are presented with (c, d) and without (a, b) prior EQ.PET filtering. For each method, a group of 7 boxplots are
presented, each belonging to one necrotic core size. Each boxplot represents the distribution (mean and quartiles) of validation results from all
clinical reconstructions.
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their selection of the most appropriate method.
Based on the results presented in this study, CT is the
best performing method for all lesion types but its utility
is limited by the requirement for prior parameter tuning
using phantom data which might not be available in all
clinical sites. For the experiments performed on the real
NEMA IQ phantom data, the method parameters (a and
b) were calculated on the same data as used for the
assessment, which could result in an overly optimisticassessment of the performance of the method. However,
this was not the case for the simulated phantom data
and the performance observed with these datasets was
in agreement with the real phantom data. Furthermore,
whilst these phantom-tuned parameters perform well on
the more complex lesion shapes used in this study, we
have not evaluated their performance on heterogeneous
lesions (beyond those with a necrotic core), or lesions in
a heterogeneous background. AT40 or AT50 show only
marginally reduced performance and require no prior
Figure 6 Schematic drawing of the necrotic core spheres in the
synthetic phantom. The performance of each method has been
validated based on the ability of the method to delineate either the
inner core or outer layer, shaded areas in the left and right diagrams,
respectively.
Firouzian et al. EJNMMI Research 2014, 4:69 Page 9 of 12
http://www.ejnmmires.com/content/4/1/69tuning. AT performs especially well on small lesions
even with low contrast. CT and AT are both using back-
ground uptake information which makes them more
capable of handling small low contrast lesions. For large
high contrast lesions, most methods perform reasonable
but with different accuracy levels. Depending on the
application and availability, clinicians can decide whether
they would like to opt for slightly higher accuracy with
prior tuning or not. These findings are consistent with
a previous study comparing different PET delineation
methods (except FLAB) where they found AT40 and
CT are the best performing methods for assessing
lesion sizes in comparison to thresholding, relative
thresholding [13], absolute SUV and gradient-based
watershed [12] method [15]. We did not observe the
improved performance of FLAB relative to other
methods that has been reported by the inventors of the
method in a previous study [25]. This may be becauseFigure 7 CV of delineated volumes from the synthetic phantom with
reconstructions and acquisitions for all delineation methods with respect to
EQ.PET filtering (left). The zoomed version of the plot is shown on the righthe FLAB implementation we used had not been opti-
mised for the reconstruction protocols or types of objects
used in this study.
For methods requiring information on background
uptake (CT and AT), the background region needs to be
defined by the user which might introduce some varia-
tions in the results. For this study, it was not the case
since the phantom body is a homogeneous structure,
but in clinical practice, the background region needs to
be selected carefully. For FLAB, the background uptake
is estimated from the initial VOI and therefore the
results might vary based on different VOI selections.
FLAB allows the user to tune various parameters to the
data, but in this study, we avoided user interference to
minimise any bias in our results. The VOI definition for
thresholding methods does not introduce variations in
the lesion size but might include false positives if it is
too large.
To give a more clinical context to the results, the best
performing scenario for small spheres in the NEMA
phantom, PSF reconstruction with CT gives a mean %
VE of 2.4%± 31.0%. Of relevance to radiotherapy planning,
this translates to a mean volume error of 19.0 ml ± 66.0 ml.
For MTV-based response assessment, this translates to a
95% confidence interval of approximately 61% on the volume
measurement. For large spheres, the best scenario would be
OP-OSEM with T40 which gives a mean %VE of −2.7% ±
7.8% which is translated to a volume error of −305.4 ±
762.4 ml and translates into confidence interval of 15.3%.
Conclusions
Considering background uptake information in the de-
lineation process improves accuracy, especially for small,
low contrast and heterogeneous lesions. There was less
variation in performance for large, high contrast lesions.necrotic core spheres. The results are presented across different
necrotic core size with (dashed lines) and without (solid lines) prior
t
Figure 8 SI (a, b) and %VE (c, d) for all methods using synthetic phantom data with irregular shapes. For each method a group of 6
boxplots are presented, each belonging to one shape with (b, d) and without (a, c) prior EQ.PET filtering. Each boxplot includes the validation
results from all clinical reconstructions. In case of %VE, the y-axis range has been limited to −100 to 200 for better readability.
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additional parameter tuning that might not be possible at
all clinical sites. The accuracy of AT40 was only margin-
ally lower than CT and requires no additional parameter
tuning. Amongst the parameters investigated, lesion size
and contrast had the biggest impact on the relativeperformance of the delineation methods evaluated. The
variation in delineated volumes for small lesions, even for
the simple NEMA spheres, was generally very high (CV
greater than 1) and relatively low (CV smaller than 0.5) for
large lesions across the different reconstruction methods.
Applying EQ.PET filtering to the data prior to delineation
Figure 9 Flow chart summarising methods’ performance for each parameter setting on NEMA IQ data. The parameters are shown as
diamonds and are ordered from high to low impact from left to right. The options for each parameter are presented in rectangles and the best
performing method this type of data is presented alongside these rectangles. The methods are ordered according to accuracy and the
corresponding %VE ± SD are provided between brackets.
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http://www.ejnmmires.com/content/4/1/69reduced the variation in delineated volume for all lesion
sizes (e.g., CV less than 0.15 for lesions greater than 10-
mm diameter with AT methods). EQ.PET filtering had a
variable effect on delineation accuracy, typically improving
the performance for large lesions and reducing it for small
lesions.Abbreviations
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